Q1 EPS Estimates for Ekso Bionics Reduced by HC Wainwright

Ekso Bionics Holdings, Inc. (NASDAQ:EKSO) – Stock analysts at HC Wainwright reduced their Q1 2025 earnings estimates for Ekso Bionics in a research note issued to investors on Tuesday, March 4th. HC Wainwright analyst S. Ramakanth now expects that the company will earn ($0.11) per share for the quarter, down from their prior estimate of ($0.06). HC Wainwright currently has a “Buy” rating and a $9.00 target price on the stock. The consensus estimate for Ekso Bionics’ current full-year earnings is ($0.48) per share. HC Wainwright also issued estimates for Ekso Bionics’ Q2 2025 earnings at ($0.05) EPS, Q3 2025 earnings at ($0.06) EPS, Q4 2025 earnings at ($0.03) EPS, FY2025 earnings at ($0.25) EPS and FY2028 earnings at $0.27 EPS.

Ekso Bionics (NASDAQ:EKSO) last announced its earnings results on Monday, March 3rd. The company reported ($0.14) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.07) by ($0.07). The company had revenue of $5.09 million during the quarter, compared to analysts’ expectations of $5.05 million. Ekso Bionics had a negative return on equity of 83.09% and a negative net margin of 62.95%.

EKSO has been the subject of a number of other reports. StockNews.com started coverage on shares of Ekso Bionics in a research note on Monday. They issued a “hold” rating for the company. Lake Street Capital cut their target price on Ekso Bionics from $2.00 to $1.00 and set a “buy” rating on the stock in a research note on Tuesday.

Ekso Bionics Stock Down 8.0 %

Shares of NASDAQ:EKSO opened at $0.44 on Thursday. The stock has a market capitalization of $9.64 million, a P/E ratio of -0.67 and a beta of 1.46. The stock’s 50-day moving average price is $0.61 and its 200-day moving average price is $0.82. The company has a current ratio of 2.81, a quick ratio of 2.14 and a debt-to-equity ratio of 0.28. Ekso Bionics has a 12-month low of $0.37 and a 12-month high of $1.64.

Ekso Bionics Company Profile

Ekso Bionics Holdings, Inc designs, develops, sells, and rents exoskeleton products in the Americas, Germany, Poland, Europe, the Middle East, Africa, the Asia Pacific, and internationally. It operates in two segments, EksoHealth and EksoWorks. The EksoHealth segment designs, engineers, manufactures, and markets exoskeletons for applications in the medical markets.